Bioventus (BVS) Selling, General & Administrative (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 3.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.28 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.96 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.78 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 522.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -207.22 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 349.70 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.12 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 351.80 Mn |
| 10 | Bioventus | 535.01 Mn | 544.52 Mn | 90.77 Mn | 78.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 78.33 Mn |
| Dec 31, 2025 | 82.76 Mn |
| Sep 27, 2025 | 78.66 Mn |
| Jun 28, 2025 | 79.11 Mn |
| Mar 29, 2025 | 73.50 Mn |
| Dec 31, 2024 | 86.87 Mn |
| Sep 28, 2024 | 81.48 Mn |
| Jun 29, 2024 | 96.67 Mn |
| Mar 30, 2024 | 78.78 Mn |
| Dec 31, 2023 | 78.36 Mn |
| Sep 30, 2023 | 69.82 Mn |
| Jul 1, 2023 | 74.84 Mn |
| Apr 1, 2023 | 80.86 Mn |
| Dec 31, 2022 | 77.44 Mn |
| Oct 1, 2022 | 78.96 Mn |
| Jul 2, 2022 | 89.62 Mn |
| Apr 2, 2022 | 86.12 Mn |
| Dec 31, 2021 | 80.88 Mn |
| Oct 2, 2021 | 69.64 Mn |
| Jul 3, 2021 | 69.05 Mn |
| Apr 3, 2021 | 34.69 Mn |
| Dec 31, 2020 | 61.97 Mn |
| Sep 26, 2020 | 50.30 Mn |
| Jun 27, 2020 | 40.53 Mn |
| Mar 28, 2020 | 40.28 Mn |